P. Christopherson

发表

Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.

J. Ponder, R. Montgomery, J. Gill, 1998, Blood.

The Von Willebrand Factor Propeptide (VWFpp) Traffics an Unrelated Protein to Storage

R. Montgomery, M. A. Jozwiak, P. Christopherson, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.

D. Bellissimo, R. Montgomery, J. Gill, 2006, Molecular genetics and metabolism.

ASSAY OF THE VON WILLEBRAND FACTOR (VWF) PROPEPTIDE TO IDENTIFY TYPE 1 VON WILLEBRAND DISEASE PATIENTS WITH DECREASED VWF SURVIVAL Running Title: VWF propeptide and decreased VWF survival

D. Bellissimo, P. Morateck, R. Montgomery, 2006 .

Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.

D. Bellissimo, P. Morateck, R. Montgomery, 2006, Blood.

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

D. Bellissimo, R. Hoffmann, C. Leissinger, 2016, Blood.

Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines

M. Morgan, M. Cooke, G. Mccarthy, 2001, Molecular carcinogenesis.

Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program

D. Bellissimo, R. Montgomery, P. Christopherson, 2022, Journal of thrombosis and haemostasis : JTH.

Molecular cloning, expression, and characterization of CYP2D17 from cynomolgus monkey liver.

S. Ekins, D. Tweedie, P. Christopherson, 1999, Archives of biochemistry and biophysics.

Screening for von Willebrand disease does not impact posttonsillectomy bleeding in a low‐risk population

P. Simpson, R. Montgomery, P. Christopherson, 2021, Pediatric blood & cancer.

Laboratory variability in the diagnosis of type 2 VWD variants

R. Montgomery, P. Christopherson, T. Abshire, 2020, Journal of thrombosis and haemostasis : JTH.

Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy.

P. Simpson, R. Montgomery, J. Gill, 2020, Blood advances.

Von Willebrand disease in the United States: perspective from the Zimmerman program.

R. Montgomery, P. Christopherson, J. Cox Gill, 2018, Annals of blood.

Rapid discrimination of the phenotypic variants of von Willebrand disease.

R. Hoffmann, R. Montgomery, J. Gill, 2016, Blood.

THROMBOSIS AND HEMOSTASIS No increase in bleeding identi fi ed in type 1 VWD subjects with D 1472 H sequence variation

R. Hoffmann, C. Leissinger, R. Montgomery, 2013 .

Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD

R. Hoffmann, R. Montgomery, P. Christopherson, 2010, Journal of thrombosis and haemostasis : JTH.

Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.

R. Montgomery, J. Gill, D. Mancuso, 1996, Blood.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

D. Bellissimo, C. Leissinger, R. Montgomery, 2012, Blood.

Collagen binding provides a sensitive screen for variant von Willebrand disease.

R. Hoffmann, R. Montgomery, J. Gill, 2013, Clinical chemistry.

Critical von Willebrand factor A1 domain residues influence type VI collagen binding

D. Bellissimo, R. Montgomery, J. Gill, 2012, Journal of thrombosis and haemostasis : JTH.

Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease

R. Hoffmann, R. Montgomery, J. Gill, 2012, Journal of thrombosis and haemostasis : JTH.

Crucial role for the VWF A1 domain in binding to type IV collagen.

D. Bellissimo, R. Hoffmann, R. Montgomery, 2015, Blood.

Detection of VWF Copy Number Variations by Microarray Analysis in Von Willebrand Disease Type 3 Index Cases

D. Bellissimo, M. Hegde, R. Montgomery, 2011 .

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

R. Hoffmann, P. Morateck, R. Montgomery, 2011, Blood.

Normal range of bleeding scores for the ISTH‐BAT: adult and pediatric data from the merging project

Shamim A. Mollah, B. Coller, R. Montgomery, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

R. Hoffmann, C. Leissinger, P. Morateck, 2010, Blood.

The Prevalence of Reduced VWF Survival Phenotype (Type 1C VWD) in Type 1 Index Cases Recruited into the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB - VWD).

D. Bellissimo, C. Leissinger, R. Montgomery, 2007 .

Common VWF Haplotypes in Normal African-Americans and Caucasians Recruited into the ZPMCB-VWD and Their Impact on VWF Laboratory Testing.

D. Bellissimo, C. Leissinger, R. Montgomery, 2007 .

Type 2M von Willebrand Disease: F606I and I662F Mutations in the Glycoprotein Ib Binding Domain Selectively Impair Ristocetin- but not Botrocetin-Mediated Binding of von Willebrand Factor to Platelets

J. Ponder, J. Scott, R. Montgomery, 1998 .

the VWF activity assay by ristocetin cofactor Common VWF exon 28 polymorphisms in African Americans affecting

R. Hoffmann, C. Leissinger, P. Morateck, 2012 .

Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

Sandra L Haberichter, Elizabeth P Merricks, Scot A Fahs, 2005, Blood.

Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes

H. Cheung, G. Mccarthy, P. Christopherson, 2001, Annals of the rheumatic diseases.

Molecular Mechanism of Basic Calcium Phosphate Crystal-induced Activation of Human Fibroblasts

H. Cheung, A. Baldwin, J. A. Augustine, 1998, The Journal of Biological Chemistry.

Common VWF sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWD

D. Bellissimo, J. Johnsen, R. Montgomery, 2018, Research and practice in thrombosis and haemostasis.

von Willebrand factor antigen levels are associated with burden of rare nonsynonymous variants in the VWF gene

R. Montgomery, P. Christopherson, J. Di Paola, 2021, Blood.

THROMBOSIS AND HEMOSTASIS Crucial role for the VWF A 1 domain in binding to type IV collagen

D. Bellissimo, R. Hoffmann, R. Montgomery, 2015 .

Title: Crucial Role for the VWF A1 Domain In Binding to Type IV Collagen Short title: VWF Binds Collagen IV

D. Bellissimo, R. Hoffmann, R. Montgomery, 2015 .

Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score

R. Montgomery, P. Christopherson, P. James, 2022, Journal of thrombosis and haemostasis : JTH.

Basic calcium phosphate crystals induce synthesis and secretion of 92 kDa gelatinase (gelatinase B/matrix metalloprotease 9) in human fibroblasts

P. Christopherson, T. Pourmotabbed, L. Ryan, 1998, Annals of the Rheumatic Diseases.

Functional Assay of VWF Measured by Its Interaction with Platelet GPIb without the Use of Ristocetin.

D. Bellissimo, R. Montgomery, D. Kenny, 2007 .

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure

R. Montgomery, P. Christopherson, T. Abshire, 2022, Research and practice in thrombosis and haemostasis.

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.

R. Hoffmann, C. Leissinger, R. Montgomery, 2013, Blood.

Fourteen Percent of Healthy African Americans Participating In the Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB VWD) Are Heterozygous for the VWF Gene Mutation H817Q Associated with Type 2N Von Willebrand Disease

D. Bellissimo, R. Montgomery, J. Gill, 2010 .

Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

R. Montgomery, J. Gill, P. Christopherson, 2017 .

Clinical and laboratory phenotype variability in type 2M von Willebrand disease

L. Boggio, P. Christopherson, A. Shapiro, 2017, Journal of thrombosis and haemostasis : JTH.